ATE112166T1 - Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen. - Google Patents

Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen.

Info

Publication number: ATE112166T1
Authority: AT; Austria
Prior art keywords: dimethylamino; propyl; treatment; cerebrovascular disorders; phenylphthalene
Prior art date: 1990-09-06

Application number

AT91610063T

Other languages

English (en)

Inventor

Yoshiaki Tanaka

Naomi Kobayashi

Tadashi Kurimoto

Yugo Ikeda

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-06

Filing date

1991-08-16

Publication date

1994-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26066379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE112166(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1991-08-16 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

1994-10-15 Application granted granted Critical

1994-10-15 Publication of ATE112166T1 publication Critical patent/ATE112166T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT91610063T 1990-09-06 1991-08-16 Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen. ATE112166T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK213290A DK213290D0 (da)	1990-09-06	1990-09-06	Treatment of cerebrovascular disorders
SG165594A SG165594G (en)	1990-09-06	1994-11-16	1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Publications (1)

Publication Number	Publication Date
ATE112166T1 true ATE112166T1 (de)	1994-10-15

Family

ID=26066379

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91610063T ATE112166T1 (de)	1990-09-06	1991-08-16	Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen.

Country Status (14)

Country	Link
EP (1)	EP0474580B1 (de)
JP (1)	JPH085787B2 (de)
KR (1)	KR970002246B1 (de)
AT (1)	ATE112166T1 (de)
AU (1)	AU644204B2 (de)
CA (1)	CA2049368C (de)
DE (1)	DE69104314T2 (de)
DK (2)	DK213290D0 (de)
HK (1)	HK21595A (de)
IE (1)	IE72160B1 (de)
IL (1)	IL98968A (de)
NZ (1)	NZ239437A (de)
SG (1)	SG165594G (de)
ZA (1)	ZA916187B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1015416T3 (da) *	1997-07-08	2001-11-05	Lundbeck & Co As H	Fremgangsmåde til fremstilling af citalopram
JP4674339B2 (ja) *	1998-08-07	2011-04-20	三菱化学株式会社	脳損傷の予防・治療剤
ES2189502T3 (es) *	1998-10-20	2003-07-01	Lundbeck & Co As H	Metodo para la prevencion de citalopram.
KR100454008B1 (ko)	1998-12-23	2004-10-20	하. 룬트벡 아크티에 셀스카브	5-시아노프탈리드의 제조방법
SI1173431T2 (sl)	1999-04-14	2009-12-31	Lundbeck & Co As H	Postopek za pripravo citaloprama
ITMI991581A1 (it) *	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
GB2357762B (en)	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
BG64901B1 (bg) *	2000-05-29	2006-08-31	H. Lundbeck A/S	Метод за получаване на циталопрам
IL144816A (en)	2000-08-18	2005-09-25	Lundbeck & Co As H	Method for the preparation of citalopram
ES2228824T3 (es) *	2000-12-22	2005-04-16	H. Lundbeck A/S	Metodo de preparacion de citalopram puro.
BG65515B1 (bg) *	2002-07-26	2008-10-31	H. Lundbeck A/S	Метод за получаване на 5-цианофталид
DK1691811T3 (da)	2003-12-11	2014-10-20	Sunovion Pharmaceuticals Inc	Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
TW200812993A (en) *	2006-05-02	2008-03-16	Lundbeck & Co As H	New uses of escitalopram
EP2008653A1 (de)	2007-06-28	2008-12-31	Charité-Universitätsmedizin Berlin	Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten
DE102007051090A1 (de)	2007-06-28	2009-01-08	Charité - Universitätsmedizin Berlin	SSRI zur Behandlung neuronaler Krankheiten
CN104005415B (zh) *	2014-02-18	2015-12-02	中铁十六局集团北京轨道交通工程建设有限公司	微风化花岗岩中地下连续墙的高效成槽施工方法
CN106871753B (zh) *	2017-01-04	2018-10-16	中铁隧道集团有限公司	一种用于提高水平岩层隧道成型的装药方法

1990
- 1990-09-06 DK DK213290A patent/DK213290D0/da not_active Application Discontinuation
1991
- 1991-07-25 IL IL9896891A patent/IL98968A/en not_active IP Right Cessation
- 1991-07-30 IE IE268291A patent/IE72160B1/en not_active IP Right Cessation
- 1991-08-06 ZA ZA916187A patent/ZA916187B/xx unknown
- 1991-08-16 DE DE69104314T patent/DE69104314T2/de not_active Expired - Lifetime
- 1991-08-16 DK DK91610063.9T patent/DK0474580T3/da active
- 1991-08-16 EP EP91610063A patent/EP0474580B1/de not_active Expired - Lifetime
- 1991-08-16 NZ NZ239437A patent/NZ239437A/en not_active IP Right Cessation
- 1991-08-16 AT AT91610063T patent/ATE112166T1/de not_active IP Right Cessation
- 1991-08-16 CA CA002049368A patent/CA2049368C/en not_active Expired - Lifetime
- 1991-08-19 KR KR1019910014255A patent/KR970002246B1/ko not_active Expired - Fee Related
- 1991-08-20 AU AU82594/91A patent/AU644204B2/en not_active Ceased
- 1991-09-04 JP JP3224192A patent/JPH085787B2/ja not_active Expired - Fee Related
1994
- 1994-11-16 SG SG165594A patent/SG165594G/en unknown
1995
- 1995-02-16 HK HK21595A patent/HK21595A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0474580A3 (en)	1992-06-03
CA2049368A1 (en)	1992-03-07
IL98968A0 (en)	1992-07-15
EP0474580B1 (de)	1994-09-28
IE912682A1 (en)	1992-03-11
NZ239437A (en)	1997-02-24
JPH085787B2 (ja)	1996-01-24
CA2049368C (en)	2001-10-23
ZA916187B (en)	1992-04-29
AU644204B2 (en)	1993-12-02
AU8259491A (en)	1992-03-12
IL98968A (en)	1996-06-18
DK0474580T3 (da)	1995-04-03
HK21595A (en)	1995-02-24
DK213290D0 (da)	1990-09-06
KR970002246B1 (ko)	1997-02-26
SG165594G (en)	1995-05-12
IE72160B1 (en)	1997-03-26
EP0474580A2 (de)	1992-03-11
KR920005983A (ko)	1992-04-27
DE69104314T2 (de)	1995-02-16
DE69104314D1 (de)	1994-11-03
JPH04244024A (ja)	1992-09-01

Publication	Publication Date	Title
ATE112166T1 (de)	1994-10-15	Verwendung von 1-(3-(dimethylamino)propyl>-1- phenylphthalenen zur behandlung zerebrovaskulärer störungen.
NO922147D0 (no)	1992-05-29	Heterocykliske derivater
ATE168007T1 (de)	1998-07-15	Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
DK0646115T3 (da)	2003-04-22	Heterocykliske/cykliske aminderivater
DK0530505T3 (da)	1996-02-12	Hydantoinderivater
FI913478A0 (fi)	1991-07-18	Diazinderivat.
DE69200160D1 (de)	1994-07-07	Angiotensin-II-Antagonisten.
ES2132284T3 (es)	1999-08-16	Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
DE3888340D1 (de)	1994-04-14	Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE79257T1 (de)	1992-08-15	Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE69018726D1 (de)	1995-05-24	Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen.
DE69307674D1 (de)	1997-03-06	HIV-Proteaseinhibitoren und ihre Verwendung zur Behandlung von AIDS
ES8602723A1 (es)	1985-12-01	Un procedimiento para la preparacion de nuevas n-bencil-propilaminas sustituidas.
DE69827706D1 (de)	2004-12-30	5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ATE53205T1 (de)	1990-06-15	Methioninsubstituierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung.
DE3650311D1 (de)	1995-06-01	Verwendung von Quinazolinen zur Herstellung eines Arzneimittels zur Behandlung und Vorbeugung von Arrhythmie.
ATE186912T1 (de)	1999-12-15	Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
RO95572A2 (ro)	1988-09-30	Procedeu pentru prepararea unor derivati de 1,3-oxazolidin-2-ona
ATE160567T1 (de)	1997-12-15	Psoralen-derivate, deren herstellung und verwendung als arzneimittel
DE68906028D1 (de)	1993-05-19	Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date	Code	Title	Description
1995-04-15	UEP	Publication of translation of european patent specification
2011-05-15	REN	Ceased due to non-payment of the annual fee